SurgicEye and Crystal Photonics show their solutions for radio guided surgery at EANM (joint booth number 236). The offered products go from gamma probes providing acoustic feedback to 3D imaging and navigation as provided by the declipse®SPECT device. Several devices will be on the booth and you could get hands-on sessions with the team from both companies. We are looking forward to seeing you soon.
SurgicEye and Crystal Photonics show their solutions for radio guided surgery at EANM (joint booth number 099). The offered products go from gamma probes providing acoustic feedback to 3D imaging and navigation as provided by the declipse®SPECT device. Several devices will be on the booth and you could get hands-on sessions with the team from both companies. We are looking forward to seeing you soon.
Prof. Dr. René HornungHead of Department of Gynecology Kantonsspital St. Gallen, Switzerland
The 3D declipse®SPECT Laparoscopy technology opens new horizons to minimally invasive
surgery in gynecologic oncology. Sentinel lymph node biopsy during
laparoscopic procedures seems to be easily feasible and may in the near future
become standard of care for cervical and endometrial cancers.
Dr. Omgo E. NiewegSurgeon, The Netherlands Cancer Institute Amsterdam, the Netherlands
The innovative 3D declipseSPECT technology may make the sentinel node biopsy easier and more
reliable. New technologies like 3D declipseSPECT will also open up lymphatic mapping to additional
cancer types in locations with a more intricate anatomy and cancer types with more
complex lymph drainage.
Dr. Sergi Vidal SicartNuclear Medicine Specialist, Hospital Clínic Barcelona, Spain
The 3D declipseSPECT presents a potential tool in refining the excision margins of tumor in the
ROLL technique. The possibility to observe the harvested tissue and the tracer activity within it offers
a realistic view of the surgical procedure suited for the operating room.
Prof. Dr. Marion KiechleDirector of the Women’s Hospital Klinikum rechts der Isar Munich, Germany
The declipse®SPECT technology and its intraoperative use for navigated sentinel lymph node dissection
enables safer surgeries, and less invasive procedures. This can ensure a high quality outcome for
every individual patient.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
You can adjust all of your cookie settings by navigating the tabs on the left-hand side.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
The 3D declipse®SPECT Laparoscopy technology opens new horizons to minimally invasive surgery in gynecologic oncology. Sentinel lymph node biopsy during laparoscopic procedures seems to be easily feasible and may in the near future become standard of care for cervical and endometrial cancers.
The innovative 3D declipseSPECT technology may make the sentinel node biopsy easier and more reliable. New technologies like 3D declipseSPECT will also open up lymphatic mapping to additional cancer types in locations with a more intricate anatomy and cancer types with more complex lymph drainage.
The 3D declipseSPECT presents a potential tool in refining the excision margins of tumor in the ROLL technique. The possibility to observe the harvested tissue and the tracer activity within it offers a realistic view of the surgical procedure suited for the operating room.
The declipse®SPECT technology and its intraoperative use for navigated sentinel lymph node dissection enables safer surgeries, and less invasive procedures. This can ensure a high quality outcome for every individual patient.
